Sospecha clínica, diagnóstico y seguimiento de la amiloidosis cardíaca: documento de actualización y resumen ejecutivo

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Revista clínica española (Ed. impresa)

• Publication date

  2024-05-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.rce.2024.03.007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• [Transthyretin amyloid cardiomyopathy].

  2025cited by this paper
• 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee.

  2023cited by this paper
• Estimating the Prevalence of Cardiac Amyloidosis in Old Patients with Heart Failure—Barriers and Opportunities for Improvement: The PREVAMIC Study

  2023cited by this paper
• Musculoskeletal co‐morbidities in patients with transthyretin amyloid cardiomyopathy: a systematic review

  2023cited by this paper
• World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

  2023cited by this paper
• Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS)

  2022cited by this paper
• Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK

  2022cited by this paper
• It Takes a Village: Multimodality Imaging of Cardiac Amyloidosis

  2022cited by this paper
• Prevalence of Orthopedic Manifestations in Patients With Cardiac Amyloidosis With a Focus on Shoulder Pathologies.

  2022cited by this paper
• Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years

  2022cited by this paper
• Multidisciplinary amyloidosis care in the era of personalized medicine

  2022cited by this paper
• Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

  2022cited by this paper
• ATTR Amyloidosis: Current and Emerging Management Strategies

  2021cited by this paper
• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

  2021cited by this paper
• Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis

  2021cited by this paper
• Hand surgeons and amyloidosis specialists warning: transthyretin-associated amyloidosis with bifid median nerve as a cause of bilateral carpal tunnel syndrome. A case report and literature review

  2021cited by this paper
• Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis.

  2021cited by this paper
• Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.

  2021cited by this paper
• Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness

  2021cited by this paper
• Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic

  2020cited by this paper
• Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis

  2020cited by this paper
• The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update

  2020cited by this paper
• [Transthyretin amyloidosis: What we now see is just the tip of the iceberg].

  2020cited by this paper
• Heart failure from ATTRwt amyloid cardiomyopathy is associated with poor prognosis

  2020cited by this paper
• Epidemiology of heart failure

  2020cited by this paper
• Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies

  2020cited by this paper
• Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

  2020cited by this paper
• How to Image Cardiac Amyloidosis: A Practical Approach.

  2020cited by this paper
• Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis.

  2019cited by this paper
• Recomendaciones de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología para la valoración de la fragilidad en el anciano con cardiopatía

  2019cited by this paper
• Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?

  2019cited by this paper
• Treatment of cardiac transthyretin amyloidosis: an update.

  2019cited by this paper
• Remote Management of Heart Failure: An Overview of Telemonitoring Technologies

  2019cited by this paper
• Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.

  2019cited by this paper
• Advances in the treatment of hereditary transthyretin amyloidosis: A review

  2019cited by this paper
• Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.

  2019cited by this paper
• Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.

  2019cited by this paper
• Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.

  2019cited by this paper
• Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

  2018cited by this paper
• Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

  2018cited by this paper
• Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release.

  2018cited by this paper
• Cardiac amyloidosis: An update on diagnosis and treatment

  2017cited by this paper
• Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

  2017cited by this paper
• Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths

  2017cited by this paper
• Diagnóstico y tratamiento de la amiloidosis cardiaca por transtiretina. Progreso y esperanza.

  2017cited by this paper
• Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis

  2017cited by this paper
• Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?

  2017cited by this paper
• Medical resource use and expenditure in patients with chronic heart failure: a population‐based analysis of 88 195 patients

  2016cited by this paper
• “Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy

  2016cited by this paper
• Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?

  2016cited by this paper
• Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure.

  2016cited by this paper
• Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System.

  2016cited by this paper
• Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

  2016cited by this paper
• Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.

  2016cited by this paper
• Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

  2015cited by this paper
• Cardiac amyloidosis: the great pretender

  2015cited by this paper
• Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.

  2015cited by this paper
• Contribution of Electrocardiogram in the Differentiation of Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy.

  2015cited by this paper
• Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.

  2014cited by this paper
• Comorbidity in heart failure. Results of the Spanish RICA Registry.

  2014cited by this paper
• Heart failure: preventing disease and death worldwide

  2014cited by this paper
• Epidemiología de la insuficiencia cardiaca en España en los últimos 20 años

  2013cited by this paper
• Carpal tunnel syndrome and trigger digit: common diagnoses that occur "hand in hand".

  2013cited by this paper
• Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.

  2012cited by this paper
• Cardiac transthyretin amyloidosis

  2012cited by this paper
• Wild-type transthyretin-derived amyloidosis in various ligaments and tendons.

  2011cited by this paper
• [Amyloidosis. Also a heart disease].

  2011cited by this paper
• Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types

  2009cited by this paper
• Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.

  2005cited by this paper

• Insuficiencia cardíaca con fracción de eyección preservada: actualización en estrategias diagnósticas y terapéuticas. Documento de consenso de la SEMI

  2026cites this paper
• Transforming Care for Transthyretin Amyloidosis: Findings and Recommendations from the CARABELA Initiative

  year unknowncites this paper